Trump Sets 60-Day Deadline for Drugmakers to Slash U.S. Prices: What This Could Mean for Pharma Stocks and Healthcare Investors
President Trump’s recent bold move to pressure major pharmaceutical companies into slashing U.S. drug prices within 60 days is more than just political posturing—it signals a potential seismic shift in the healthcare investment landscape that … Read more